BackMercury Biopharmaceutical Overview

Mercury Biopharmaceutical Total Liabilities

Track Mercury Biopharmaceutical's total liabilities ($59M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$59.12M
↓ 8.61% YoYΔ $-5.57M vs prior year quarter

Peer trimmed avg / median

Loading

Mercury Biopharmaceutical Total Liabilities History

Loading

Mercury Biopharmaceutical vs. peers: Total Liabilities Comparison

Loading

Mercury Biopharmaceutical Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Mercury Biopharmaceutical (6932.TWO) FAQ

Mercury Biopharmaceutical (6932.TWO) currently reports a total liabilities of $59M as of June 2026. That compares with $65M in the prior-year period — down 8.6% year over year. Use the charts on this page to explore Mercury Biopharmaceutical's total liabilities history and peer comparisons.

Mercury Biopharmaceutical's total liabilities decreased from $65M to $59M — a 8.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mercury Biopharmaceutical reported $59M in total liabilities as of June 2026. That compares with $65M in the prior-year period — down 8.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $59M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mercury Biopharmaceutical, and consider following 6932.TWO for alerts when major investors trade the stock.